- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02543164
Influence of Beta-glucan Enriched Barley Flour in Bread on Glycemic Response
Comparison of the Glycemic Response of Consumption of Bread Enriched With Barley Beta-glucans With White Bread. Controlled Intervention Trial. A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective of the study is to investigate the influence of beta-glucan enriched barley flour as constituent of bread on glycaemic response (GR) in healthy human volunteers. Glycaemic response will be measured as the area under the curve (AUC) of blood glucose after consumption of barley bread(s), and compared with AUC for white bread. Measurements will be done in line with recommendations. In line with recommendations ten healthy human volunteers will be tested to obtain a sufficient statistical power. GR measurement will be based on available carbohydrates. Amount of bread will be standardised to contain 50 g of available carbohydrates. Subjects will consume bread sample with 250 mL of water, within 10-15 minutes. Blood sampling times will be at 0 min (baseline sample), followed by 15, 30, 45, 60, 90 and 120 min after starting to eat the test meal. Glucose levels will be measured in capillary blood. For reference and test meals, the investigators will do at least 2 AUC measurements per subject. AUC calculation will be based on incremental AUC, ignoring area under the baseline. Comparison will be done as the mean of the individual ratios.
The differences between the different products ingested will be analyzed with the statistical test of analysis of variance. In case of failure to find homogeneity in the variances the nonparametric ANOVA, the Kruskal-Wallis test, will be used. The results will be expressed as mean ± standard deviation for each with a significance level of 0.05 for all the statistical tests.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Willingness' to participate, self-diagnosed as healthy
- Age: 18-65 years
Exclusion Criteria:
- Allergy or intolerances to ingredients of tested products (bread)
- Renal impairment
- Diagnosed diabetes
- Level of glucose above 5.6mmol/l at first measurement
- Thyroid disease
- Use of medicines for lowering blood fats and/or preparations for weight loss or reducing the absorption of nutrients from the digestive tract
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: REFERENCE: white bread
Participants will consume a meal standardised to contain 50 g of available carbohydrates.
Sample Will be consumed together with 250 mL of water, within 10-15 minutes.
|
Determination of glycemic response after consumption of white bread: Capillary glucose will be taken at 0 min (baseline sample), followed by 15, 30, 45, 60, 90 and 120 min after starting to eat the meal to calculate the area under the curve (AUC). |
Other: TEST: b-glucan enriched bread
Participants will consume a meal standardised to contain 50 g of available carbohydrates.
Sample Will be consumed together with 250 mL of water, within 10-15 minutes.
|
Determination of glycemic response after consumption of bread enriched with barley beta-glucans (Test A) : Capillary glucose will be taken at 0 min (baseline sample), followed by 15, 30, 45, 60, 90 and 120 min after starting to eat the meal to calculate the area under the curve (AUC). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduced area under the curve (AUC) of blood glucose levels in bread enriched with barley beta-glucans (reduced glycemic response)
Time Frame: up to 60 days (1 day experiments)
|
Glycaemic response will be measured as the area under the curve (AUC) of blood glucose after consumption of barley bread(s), and compared with AUC for white bread.
Blood sampling times will be at 0 min (baseline sample), followed by 15, 30, 45, 60, 75, 90 and 120 min after starting to eat the test meal.
Glucose levels will be measured in capillary blood.
AUC calculation will be based on incremental AUC, ignoring area under the baseline.
Comparison will be done as the mean of the individual ratios.
Primary outcome measure is significant reducment of AUC for bread enriched with barley beta-glucans (P<0.05).
|
up to 60 days (1 day experiments)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Igor Pravst, Nutrition Institute, Slovenia
- Principal Investigator: Snežana Kocijančič, Nutrition Institute, Slovenia
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KME68/02/15
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycemic Index
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
Aga Khan UniversityUnknown
-
PepsiCo Global R&DCompletedGlycemic IndexUnited States
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
Arizona State UniversityStandard Process Inc.Terminated
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Unknown
-
Nutrition Institute, SloveniaSlovenian Research Agency; Valens Int. d.o.o., Slovenija; Community Health Centre...CompletedGlycemic IndexSlovenia
-
Azienda di Servizi alla Persona di PaviaRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
Clinical Trials on REFERENCE: white bread
-
Organización Interprofesional Agroalimentaria de...Universidad de GranadaCompleted
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustCompleted
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece
-
Paulic Meunerie SAInstitut Polytechnique UniLaSalleCompleted
-
Newcastle-upon-Tyne Hospitals NHS TrustBiotechnology and Biological Sciences Research CouncilCompleted
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece
-
University College DublinActive, not recruitingGlucose Intolerance | Healthy Subjects | Postprandial Hyperglycemia | Glycemic Control | Diabetes Mellitus RiskIreland
-
Ohio State UniversityUSDA Beltsville Human Nutrition Research CenterActive, not recruitingInflammation | PreDiabetes | Endotoxemia | DysbiosisUnited States
-
Glycemic Index Laboratories, IncUniversity of Guelph; Guelph Research and Development Centre, Agriculture and...Completed
-
University of ReadingBiotechnology and Biological Sciences Research CouncilCompletedCardiovascular Risk FactorUnited Kingdom